Wei Dong
Impact in
- Neurology top 5%
- Intracerebral and Subarachnoid Hemorrhage Research
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Surgery 20
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
- Epidemiology 18
- Acute Ischemic Stroke Management 6
- Co-authors
- Guanghui Deng (6 shared papers)Wenpeng Cai (6 shared papers)Tianya Hou (11 shared papers)Bo Wu (10 shared papers)Zilong Hao (6 shared papers)Chunyan Lei (5 shared papers)Sen Lin (9 shared papers)Xiaofei Mao (7 shared papers)
- Journals
- PLoS ONE (3 papers)Medicine (3 papers)CNS Neuroscience & Therapeutics (3 papers)Frontiers in Psychiatry (3 papers)Neuroscience (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Wei Dong
154 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 157
- Neurology 184
- Hepatology 89
- Neurology 87
- Critical Care and Intensive Care Medicine 46
- Nephrology 68
Countries citing papers authored by Wei Dong
This map shows the geographic impact of Wei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Dong more than expected).
Fields of papers citing papers by Wei Dong
This network shows the impact of papers produced by Wei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Dong. The network helps show where Wei Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 139 | |
| 2 | 2009 | 106 | |
| 3 | 2020 | 75 | |
| 4 | 2017 | 70 | |
| 5 | 2015 | 63 | |
| 6 | 2012 | 53 | |
| 7 | 2014 | 49 | |
| 8 | 2024 | 47 | |
| 9 | 2011 | 44 | |
| 10 | 2020 | 43 | |
| 11 | 2016 | 42 | |
| 12 | 2013 | 42 | |
| 13 | 2013 | 40 | |
| 14 | 2020 | 39 | |
| 15 | 2021 | 38 | |
| 16 | 2012 | 38 | |
| 17 | Genistein suppresses retinoblastoma cell viability and growth and induces apoptosis by upregulating miR-145 and inhibiting its target ABCE1. | 2017 | 34 |
| 18 | 2014 | 33 | |
| 19 | 2015 | 33 | |
| 20 | 2021 | 32 |
About Wei Dong
Wei Dong is a scholar working on Surgery, Epidemiology, Molecular Biology, Neurology and Pulmonary and Respiratory Medicine, having authored 167 papers that have together received 2.3k indexed citations. Recurring topics across this work include Intracerebral and Subarachnoid Hemorrhage Research (12 papers), COVID-19 and Mental Health (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Acute Ischemic Stroke Management (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Healthcare professionals’ stress and burnout (5 papers), Fungal Biology and Applications (5 papers) and Advanced Neuroimaging Techniques and Applications (5 papers). The work is most often cited by research in Neurology (184 citations), Hepatology (89 citations), Neurology (87 citations), Critical Care and Intensive Care Medicine (46 citations) and Nephrology (68 citations). Wei Dong has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Guanghui Deng, Wenpeng Cai, Tianya Hou, Bo Wu, Zilong Hao, Chunyan Lei, Sen Lin, Xiaofei Mao, Wendan Tao and Allan Z. Zhao. Their work appears in journals such as PLoS ONE, Medicine, CNS Neuroscience & Therapeutics, Frontiers in Psychiatry and Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.